Psyence Biomedical Ltd (PBM)’s stock is trading at $0.84 at the moment marking a fall of -7.07% from the last session close. As of this writing, shares are priced at -96.00% less than their 52-week high of $21.12, and -0.99% over their 52-week low of $0.85. Based on the past 30-day period, the stock price is -55.14% below the high and +5.42% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, PBM’s SMA-200 is $3.9401.
PBM’s price to book ratio for the most recent quarter was 0.13, resulting in an 0.22 price to cash per share for the period.
How does Psyence Biomedical Ltd (PBM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Psyence Biomedical Ltd (NASDAQ: PBM) Ownership Details
I will give a breakdown of the key shareholders in Psyence Biomedical Ltd (PBM). Recent figures show that the company’s insiders hold 16.95% of shares. A total of 8 institutional investors hold shares in the company, making 10.06% of its stock and 12.12% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is Parallel Advisors, LLC holding total of 151.25 shares that make 8.08% of the company’s total number of shares and are currently priced at 0.13 million.
The securities firm Virtu Financial LLC holds 10.32 shares of PBM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.55%, and the holding percentage of shares is valued at 8970.0.
An overview of Psyence Biomedical Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Psyence Biomedical Ltd (PBM) traded 2,808,792 shares per day, with a moving average of $1.4953 and price change of -0.6666. With the moving average of $2.3278 and a price change of -2.7166, about 1,611,879 shares changed hands on average over the past 50 days. Finally, PBM’s 100-day average volume is 1,746,984 shares, alongside a moving average of $2.9069 and a price change of -1.5166.
